School of Medicine

Carlos A. Perez, MD, an internationally renowned cancer researcher and professor emeritus of radiation oncology at the School of Medicine, died Aug. 21 in Springfield, Mo.

Researchers led by the School of Medicine’s Linda J. Richards published a study describing some of the earliest events in brain development. The findings lay the groundwork for understanding the roots of brain conditions such as epilepsy, autism and intellectual disability.

Thomas M. Maddox, MD, a professor of medicine at the School of Medicine, has been invited to become an active participant of the National Academy of Medicine’s Digital Health Action Collaborative Stakeholder Network.

Fewer than half of people worldwide who have already had one heart attack or stroke take daily aspirin to prevent a second one, according to a new study led by researchers at the School of Medicine. Increasing daily aspirin use in such patients could reduce cardiovascular deaths.

Siyuan Ding, an assistant professor of molecular microbiology at the School of Medicine, has received the 2023 Ann Palmenberg Junior Investigator Award from the American Society of Virology.

For people who have contracted the COVID-19 virus, pain and suffering may continue two years after infection, according to a new study from the School of Medicine and the Veterans Affairs St. Louis Health Care system.

A new test for two blood cancers — developed by a team at the School of Medicine — is the first whole-genome sequencing test for cancer to be approved for reimbursement by the Centers for Medicare & Medicaid Services.

The Food and Drug Administration has granted full approval to Leqembi for patients in the early stages of Alzheimer’s disease. The School of Medicine’s Barbara Joy Snider, MD, PhD, answers questions about the drug.

Sarah Ackerman, an assistant professor of pathology and immunology at the School of Medicine, has received a 2023 Klingenstein-Simons Fellowship Award in Neuroscience.

Led by the School of Medicine and other institutions around the world, the Clinical Proteomic Tumor Analysis Consortium has completed a deep analysis of the proteins driving cancer across multiple tumor types. The findings could help lead to new therapies.